| Fomesafen |
Carbon nanotube (CNT) |
SWV |
0.30–40 mg L−1
|
0.089 mg L−1
|
182
|
| Methyl parathion |
ZrO2-nanoparticles |
SWV |
5.0–3000.0 ng mL−1
|
2.0 ng mL−1
|
183
|
| Diazinon |
Carbon nanotubes (CNTS) |
DPV |
1 × 10−10 to 6 × 10−8 M |
4.5 × 10−10 M |
184
|
| Cd(ii) |
Bismuth nanoparticles |
SWASV |
1–100 ppb |
0.81 ppb |
192
|
| Pb(ii) |
1–100 ppb |
0.65 ppb |
| Ni(ii) |
10–150 ppb |
5.47 ppb |
| Cd2+
|
Antimony nanoparticles (SbNPs)/multiwalled carbon nanotubes (MWCNT) |
SWASV |
10.0–60.0 μg L−1
|
0.77 μg L−1
|
193
|
| Pb2+
|
0.65 μg L−1
|
| Pb2+
|
Gold nanoparticles (Au NPs) |
SWASV |
50–500 μg L−1
|
9.178 μg L−1
|
194
|
| Cd2+
|
200–700 μg L−1
|
86.327 μg L−1
|
| Cu2+
|
200–700 μg L−1
|
85.373 μg L−1
|
| Cd2+
|
Graphene/TMU-16-NH2([Zn2(NH2-BDC)2(4-bpdh)]·3DMF) metal–organic framework (MOF) [graphene/MOF (TMU-16-NH2)] |
DPV |
0.7–120 μg L−1
|
0.2 μg L−1
|
195
|
| Cu2+
|
Silica nanoparticles/Schiff base ligand (L/SiO2 NPs) |
SWASV |
4.0–400.0 ng mL−1
|
0.28 ng mL−1
|
196
|
| Cd2+
|
5.0–700.0 ng mL−1
|
0.54 ng mL−1
|
| Hg2+
|
Carbon ionic liquid/ion imprinted polymeric (IIP) nanobeads |
DPV |
0.5 nM to 2.0 μM |
0.1 nM |
197
|
| Sn2+
|
Clinoptilolite nano-particles (CNP)/hexadecyltrimethyl ammonium bromide surfactant (HDTMA)/dithizone (DZ) CNP/HDTMA/DZ |
SWV |
1 × 10−8 - 1 × 10−2 M |
9 × 10−9 M |
198
|
| Silver(i) |
Poly(methylene disulfide) nanoparticles (PMDSNPs) |
DPASV |
3.0 × 10−12 to 1.0 × 10−9 M |
1.0 × 10−13 M |
199
|
| Silver(i) |
Magnetic silver ion imprinted polymer nanoparticles (mag-IIP-NPs) Fe3O4@SiO2@IIP |
DPV |
0.05–150 μg L−1
|
15 ng L−1
|
200
|
| Sulfite |
Benzoylferrocene (BF)/ionic liquid (n-hexyl-3-methylimidazolium hexafluoro phosphate)/graphene nano-sheets |
SWV |
5.0 × 10−8 to 2.5 × 10−4 M |
20.0 nM |
205
|
| Hydrazine |
Ionic liquid (2-(4-oxo-3-phenyl-3,4-dihydroquinazolinyl)-N′-phenyl hydrazinecarbothioamide)/magnetic core/shell Fe3O4@SiO2/MWCNT nanocomposite |
SWV |
7.0 × 10−8 to 5.0 × 10−4 M |
40.0 nM |
206
|
| Sulfite |
Ferrocene (FC)/multiwall carbon nanotubes (MWCNTs) |
SWV |
0.4–120.0 μM |
0.1 μM |
207
|
| Hydroxylamine |
Benzoylferrocene (BF)/carbon nanotubes (CNTs) |
SWV |
0.9–400.0 μM |
0.1 μM |
208
|
| Hydrazine |
3-(4-Amino-3-hydroxy-biphenyl-4-yl)-acrylic acid/ZrO2 nanoparticles (ZrO2 NPs) |
SWV |
2.5 × 10−8 to 5.0 × 10−5 M |
14 nM |
209
|
| Hydrazine |
TiO2 nanoparticles/quinizarine (TiO2 NPs/QZ) |
DPV |
0.5–1900.0 μM |
77 nM |
210
|
| Hydroxylamine |
TiO2 nanoparticles/quinizarine (TiO2 NPs/QZ) |
DPV |
1.0–400.0 μM |
0.173 μM |
211
|
| Hydrazine |
TiO2 nanoparticles/Mn(iii) salen |
SWV |
3 × 10−8 to 4.0 × 10−4 M |
10.0 nM |
212
|
| Hydroxylamine |
Carbon nanotubes and 2,7-bis(ferrocenyl ethyl) fluoren-9-one (2,7-BF) |
SWV |
5.0 × 10−8 to 5.0 × 10−4 M |
15.0 nM |
213
|
| Hydroxylamine |
1,1-Bis(phenylacetyl)ferrocenele/NiO/CNTs nanocomposite (1,1-BPF/NiO/CNTs) |
SWV |
0.5–250.0 μM |
0.2 μM |
214
|
| Hydroxylamine |
CdO nanoparticles (CdO/NPs) |
SWV |
0.09–650.0 μM |
0.06 μM |
215
|
| Hydroxylamine |
Promazine hydrochloride (PHC)/multiwall carbon nanotube (MWCNT) |
DPV |
0.17–10.0 mM |
1.4 nM |
216
|
| Hydroxylamine |
8,9-Dihydroxy-7-methyl-12H-benzothiazolo[2,3-b]quinazolin-12-one -ZnO/CNTs (DMBQ/ZnO NPs/CNTs) |
SWV |
0.09–350 μM |
0.04 μM |
217
|
| Hydrazine |
ZnO/CNTs nanocomposite/N-(4-hydroxyphenyl)-3,5-dinitrobenzamide (ZnO/CNTs/HPDB) |
LSV |
0.02–550.0 μM |
8.0 nM |
218
|
| Hydrazine |
Gold-copper bimetallic nanoparticles supported on nano P zeolite (Au–Cu/NPZ) |
CV |
0.01–150 mM |
0.04 μM |
219
|
| Hydrazine |
Silver-doped zeolite L nanoparticles (Ag/L) |
CV |
10 μM to 4.0 mM |
1.5 μM |
220
|
| Hydrazine |
β-Nickel hydroxide nanoplatelets |
Amperometry |
1.0–1300.0 μM |
0.28 μM |
221
|
| Nitrite |
Chitosan-functionalized silver nanoparticles/multiwalled carbon nanotube (chit-AgNPs/MWCNT) |
Cyclic voltammograms |
100 nM to 50 μM |
30 nM |
222
|
| Paracetamol |
SnO2/SnS nanocomposite |
DPV |
1.0 to 36.0 μM |
0.06 μM |
223
|
